Desipramine Completed Phase 1 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01358968A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine